# Multi-omics Based Prediction of Treatment Response to Immunotherapy Combined with Chemotherapy in Advanced Gastric/Gastroesophageal Junction Cancer.

> **NCT06642857** · — · RECRUITING · sponsor: **Xiangdong Cheng** · enrollment: 150 (estimated)

## Conditions studied

- Advanced Gastric Carcinoma
- Advanced Gastroesophageal Junction Adenocarcinoma

## Interventions

- **OTHER:** Peripheral blood, tougue coating, saliva, and feces

## Key facts

- **NCT ID:** NCT06642857
- **Lead sponsor:** Xiangdong Cheng
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-25
- **Primary completion:** 2026-02-01
- **Final completion:** 2026-02-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2024-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06642857

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06642857, "Multi-omics Based Prediction of Treatment Response to Immunotherapy Combined with Chemotherapy in Advanced Gastric/Gastroesophageal Junction Cancer.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06642857. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*